255 related articles for article (PubMed ID: 31993051)
21. PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita.
Koga H; Recke A; Vidarsson G; Pas HH; Jonkman MF; Hashimoto T; Kasprick A; Ghorbanalipoor S; Tenor H; Zillikens D; Ludwig RJ
J Invest Dermatol; 2016 Nov; 136(11):2211-2220. PubMed ID: 27388992
[TBL] [Abstract][Full Text] [Related]
22. Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis.
Schmidt T; Hoch M; Lotfi Jad SS; Solimani F; Di Zenzo G; Marzano AV; Goebeler M; Cozzani E; Kern JS; Sitaru C; Lakoš Jukić I; Sárdy M; Uzun S; Jedlickova H; Gläser R; Kaneda M; Eming R; Göpel G; Ishii N; Greene B; Hashimoto T; Hertl M
Br J Dermatol; 2017 Dec; 177(6):1683-1692. PubMed ID: 28703393
[TBL] [Abstract][Full Text] [Related]
23. Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita.
Tukaj S; Hellberg L; Ueck C; Hänsel M; Samavedam U; Zillikens D; Ludwig RJ; Laskay T; Kasperkiewicz M
Exp Dermatol; 2015 Jun; 24(6):471-3. PubMed ID: 25739426
[TBL] [Abstract][Full Text] [Related]
24. Epidermolysis bullosa acquisita: what's new?
Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
[TBL] [Abstract][Full Text] [Related]
25. C-type lectin receptor expression is a hallmark of neutrophils infiltrating the skin in epidermolysis bullosa acquisita.
Guerrero-Juarez CF; Schilf P; Li J; Zappia MP; Bao L; Patel PM; Gieseler-Tillmann J; Murthy S; Cole C; Sverdlov M; Frolov MV; Hashimoto T; Ishii N; Rülicke T; Bieber K; Ludwig RJ; Sadik CD; Amber KT
Front Immunol; 2023; 14():1266359. PubMed ID: 37799716
[TBL] [Abstract][Full Text] [Related]
26. Induction of experimental epidermolysis bullosa acquisita by immunization with murine collagen VII.
Sesarman A; Sitaru C
Methods Mol Biol; 2013; 961():371-87. PubMed ID: 23325658
[TBL] [Abstract][Full Text] [Related]
27. Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules.
Sadeghi H; Lockmann A; Hund AC; Samavedam UK; Pipi E; Vafia K; Hauenschild E; Kalies K; Pas HH; Jonkman MF; Iwata H; Recke A; Schön MP; Zillikens D; Schmidt E; Ludwig RJ
J Immunol; 2015 Apr; 194(8):3656-63. PubMed ID: 25795756
[TBL] [Abstract][Full Text] [Related]
28. Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice.
Mihai S; Hirose M; Wang Y; Thurman JM; Holers VM; Morgan BP; Köhl J; Zillikens D; Ludwig RJ; Nimmerjahn F
Front Immunol; 2018; 9():535. PubMed ID: 29616034
[TBL] [Abstract][Full Text] [Related]
29. Propranolol Off-Target: A New Therapeutic Option in Neutrophil-Dependent Dermatoses?
Maglie R; Solimani F; Quintarelli L; Hertl M
J Invest Dermatol; 2020 Dec; 140(12):2326-2329. PubMed ID: 33222759
[TBL] [Abstract][Full Text] [Related]
30. T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita.
Bieber K; Witte M; Sun S; Hundt JE; Kalies K; Dräger S; Kasprick A; Twelkmeyer T; Manz RA; König P; Köhl J; Zillikens D; Ludwig RJ
Sci Rep; 2016 Dec; 6():38357. PubMed ID: 27917914
[TBL] [Abstract][Full Text] [Related]
31. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice.
Sitaru C; Chiriac MT; Mihai S; Büning J; Gebert A; Ishiko A; Zillikens D
J Immunol; 2006 Sep; 177(5):3461-8. PubMed ID: 16920988
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin.
Sitaru C; Kromminga A; Hashimoto T; Bröcker EB; Zillikens D
Am J Pathol; 2002 Jul; 161(1):301-11. PubMed ID: 12107115
[TBL] [Abstract][Full Text] [Related]
33. Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita.
Ludwig RJ; Müller S; Marques Ad; Recke A; Schmidt E; Zillikens D; Möller S; Ibrahim SM
J Invest Dermatol; 2012 May; 132(5):1409-15. PubMed ID: 22297639
[TBL] [Abstract][Full Text] [Related]
34. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
[TBL] [Abstract][Full Text] [Related]
35. The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita.
Seiler DL; Kähler KH; Kleingarn M; Sadik CD; Bieber K; Köhl J; Ludwig RJ; Karsten CM
Front Immunol; 2023; 14():1197709. PubMed ID: 37275893
[TBL] [Abstract][Full Text] [Related]
36. Skin microbiota-associated inflammation precedes autoantibody induced tissue damage in experimental epidermolysis bullosa acquisita.
Ellebrecht CT; Srinivas G; Bieber K; Banczyk D; Kalies K; Künzel S; Hammers CM; Baines JF; Zillikens D; Ludwig RJ; Westermann J
J Autoimmun; 2016 Apr; 68():14-22. PubMed ID: 26341384
[TBL] [Abstract][Full Text] [Related]
37. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita.
Woodley DT; Chang C; Saadat P; Ram R; Liu Z; Chen M
J Invest Dermatol; 2005 May; 124(5):958-64. PubMed ID: 15854036
[TBL] [Abstract][Full Text] [Related]
38. Preventive but Not Therapeutic Topical Application of Local Anesthetics Can Inhibit Experimental Epidermolysis Bullosa Acquisita in Mice.
Wen L; Dong X; Li Q; Schramm G; Zhang B; Zillikens D; Ludwig RJ; Petersen F; Yu X
Front Immunol; 2021; 12():750160. PubMed ID: 34712239
[TBL] [Abstract][Full Text] [Related]
39. T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita.
Sitaru AG; Sesarman A; Mihai S; Chiriac MT; Zillikens D; Hultman P; Solbach W; Sitaru C
J Immunol; 2010 Feb; 184(3):1596-603. PubMed ID: 20038644
[TBL] [Abstract][Full Text] [Related]
40. Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita.
Sesarman A; Sitaru AG; Olaru F; Zillikens D; Sitaru C
J Mol Med (Berl); 2008 Aug; 86(8):951-9. PubMed ID: 18542899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
